Your browser doesn't support javascript.
loading
Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive Disorder.
Seo, Eun Hyun; Kim, Seung-Gon; Lee, Jae-Hon; Yoon, Hyung-Jun.
Afiliación
  • Seo EH; Premedical Science, College of Medicine, Chosun University, Gwangju, Korea.
  • Kim SG; Department of Psychiatry, College of Medicine, Chosun University, Gwangju, Korea.
  • Lee JH; Department of Psychiatry, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
  • Yoon HJ; Department of Psychiatry, College of Medicine, Chosun University, Gwangju, Korea.
Clin Psychopharmacol Neurosci ; 21(3): 604-608, 2023 Aug 31.
Article en En | MEDLINE | ID: mdl-37424428
ABSTRACT
Lamotrigine and aripiprazole have shown efficacy as augmentation agents of serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder (OCD). To date, the efficacy of lamotrigine/aripiprazole augmentation has not been reported in OCD treatment. Herein, we report the case of a 37-year-old male with severe OCD and comorbid depression whose symptoms markedly improved after low-dose lamotrigine/aripiprazole augmentation to clomipramine. Our report suggests that early glutamatergic/antipsychotic augmentation contributes to rapid remission of OCD symptoms.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Psychopharmacol Neurosci Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Psychopharmacol Neurosci Año: 2023 Tipo del documento: Article